Newsworthy.ai is a different kind of newswire, built for the way news is consumed today. Created by the founders of PRWeb, Newsworthy.ai combines traditional newswire distribution features with influencer marketing, blockchain technology and machine learning to increase the visibility, engagement and promotion of your news.
RSS Feed for Newsworthy.aiDecember 30, 2023 — IV vitamin therapy ensures the direct absorption of essential micronutrients, antioxidants, vitamins, and minerals, maximizing their effectiveness compared to traditional oral intake methods. This innovative therapy not only helps combat nutrient deficiencies but also plays a crucial role in reducing inflammation and encouraging healing.
December 30, 2023 — A ground-breaking treatment for depression utilizing Ketamine has emerged, offering new hope for patients seeking a rapid improvement in their mood. Unlike traditional antidepressants that primarily target specific neurotransmitters in the brain, Ketamine affects a wide range of neurotransmitters and neural pathways, resulting in its unique action.
December 29, 2023 — Dr. Tola, a highly regarded psychiatrist and emotional wellness strategist, is thrilled to announce the launch of TMS Therapy as a breakthrough treatment option for patients struggling with depression.
December 29, 2023 — Innovative Psychedelics, a leading clinic specializing in IV ketamine therapy, has expanded its services to include the treatment of chronic pain. Located at 3221 N Sheffield Ave, Suite C-1S in Chicago, the clinic aims to provide effective relief for patients suffering from conditions such as cancer, CRPS, fibromyalgia, neuropathic pain, and more.
December 29, 2023 — Suniasol Integrative Mental Health & Ketamine Clinic is pleased to announce the launch of their Women's Empowerment Ketamine Series, a specialized program aimed at providing transformative support for women suffering from major depressive disorder (MDD) and other mental health conditions.
December 29, 2023 — Depression Treatment in California, a leading mental health facility, is pleased to announce the launch of its intensive outpatient program (IOP) designed to provide comprehensive support to adults struggling with depression.
December 29, 2023 — Ketamine, a drug predominantly used in anesthesia since the 1960s is now being explored as a promising treatment for various psychiatric conditions. Recent studies have shown its efficacy in alleviating depression, anxiety, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and chronic pain conditions.
December 29, 2023 — The Holistic Mental Health Clinic, a leading provider of evidence-based natural treatments for mental health, is pleased to announce that they offer Cognitive-Behavioral Therapy (CBT) to individuals seeking effective solutions for anxiety, depression, addiction, phobias, and other mental health issues.
December 29, 2023 — Depression, a prevalent and complex mood disorder affecting millions worldwide, often fails to respond to conventional therapies. However, a breakthrough treatment, Ketamine, has emerged as a promising solution for individuals with treatment-resistant depression.
December 28, 2023 — Music City Ketamine, a leading provider of mental health services, is proud to offer Ketamine Therapy Services designed to help individuals overcome mental health challenges and reclaim their lives. With a personalized approach tailored to each patient's unique needs and goals, Music City Ketamine is committed to providing transformative treatment.
December 28, 2023 — Ketamine treatment is proving to be a breakthrough therapy for individuals struggling with obsessive-compulsive disorder (OCD). By promoting neuroplasticity and facilitating positive emotional processing, ketamine offers rapid relief and the potential for long-lasting improvement to those suffering from this debilitating mental health condition.
December 28, 2023 — New Brain Institute, a leading brain health center, is excited to offer ketamine therapy for the treatment of depression in Los Angeles and Beverly Hills. New Brain Institute specializes in using SPRAVATO™, an FDA-approved breakthrough treatment for major depression disorder (MDD), alongside oral antidepressants.
December 28, 2023 — Brandon TMS and Psychiatry, a reputable psychiatric clinic, is proud to provide innovative and FDA-approved treatments for depression, including transcranial magnetic stimulation(TMS).
December 28, 2023 — The Infusionist, a trusted source for transformative healing, is proud to offer innovative in-office ketamine therapy for individuals seeking to enhance their mental well-being. The Infusionist provides personalized attention and professional guidance, ensuring a safe and nurturing environment for individuals' emotional wellness.
December 28, 2023 — IV Vitamin Therapy, also known as intravenous therapy, is revolutionizing the health and wellness industry by providing a method of delivering fluids, vitamins, and minerals directly into the bloodstream through an IV drip.
December 28, 2023 — Ketamine, a medication initially developed as an anesthetic, has emerged as a promising treatment option for various mental health and pain conditions. Recently gaining attention for its remarkable effects, ketamine provides a glimmer of hope to individuals suffering from severe depression, anxiety, PTSD, OCD, and chronic pain.
December 27, 2023 — Ibogaine Clinic Inc, a pioneer in addiction treatment, has announced its cutting-edge approach to combating addiction by harnessing the unique properties of ibogaine, a natural occurring psychoactive substance, to regulate dopamine receptors.
December 23, 2023 — Lone Peak Psychiatry, a leading psychiatric clinic in Murray, Utah, is making waves in the field of mental health treatment with its specialized focus on ketamine therapy. With a team of providers trained in using ketamine to assist in the treatment of various mental health conditions.
December 23, 2023 — Prime Psychiatry, a leading psychiatric practice in Frisco and Plano, Texas, is now offering Spravato, a nasal spray medication, as an innovative treatment option for adults with treatment-resistant depression and depression with suicidal ideation. Spravato contains esketamine, a key ingredient similar to ketamine, and has shown remarkable results.
December 23, 2023 — Ketamine, a dissociative anesthetic drug initially used for general anesthesia, has emerged as a breakthrough therapy for major depression, post-traumatic stress disorder (PTSD), and suicidal ideation.